These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma. Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459 [TBL] [Abstract][Full Text] [Related]
4. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors. Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912 [TBL] [Abstract][Full Text] [Related]
5. ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures. Li J; Cao D; Jiang L; Zheng Y; Shao S; Zhuang A; Xiang D Cell Oncol (Dordr); 2024 Jun; 47(3):951-965. PubMed ID: 38150154 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma. Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622 [TBL] [Abstract][Full Text] [Related]
7. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma. Akin-Bali DF Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217 [TBL] [Abstract][Full Text] [Related]
10. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome. Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242 [TBL] [Abstract][Full Text] [Related]
11. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma. van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195 [TBL] [Abstract][Full Text] [Related]
13. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347 [TBL] [Abstract][Full Text] [Related]
14. Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer. Boru G; Grosel TW; Pilarski R; Stautberg M; Massengill JB; Jeter J; Singh A; Marino MJ; McElroy JP; Davidorf FH; Cebulla CM; Abdel-Rahman MH Genes Chromosomes Cancer; 2019 Sep; 58(9):650-656. PubMed ID: 30883995 [TBL] [Abstract][Full Text] [Related]
15. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Shah AA; Bourne TD; Murali R Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622 [TBL] [Abstract][Full Text] [Related]
16. Verification of EZH2 as a druggable target in metastatic uveal melanoma. Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003 [TBL] [Abstract][Full Text] [Related]
17. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. Chua V; Lopez-Anton M; Mizue Terai ; Ryota Tanaka ; Baqai U; Purwin TJ; Haj JI; Waltrich FJ; Trachtenberg I; Luo K; Tudi R; Jeon A; Han A; Chervoneva I; Davies MA; Aguirre-Ghiso JA; Sato T; Aplin AE Sci Signal; 2024 Jun; 17(840):eadn8376. PubMed ID: 38861613 [TBL] [Abstract][Full Text] [Related]
18. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262 [TBL] [Abstract][Full Text] [Related]
19. BAP1 germline mutation in two first grade family members with uveal melanoma. Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051 [TBL] [Abstract][Full Text] [Related]
20. BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19. Shahriyari L; Abdel-Rahman M; Cebulla C PLoS One; 2019; 14(2):e0211507. PubMed ID: 30716094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]